bluebird bio Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
bluebird bio Inc.

An SI Board Since November 2013

Posts	SubjectMarks	Bans	Symbol
163	36	0	BLUE

Emcee: Biotech Jim	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
88	CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (BLUE), a clinical-stage c	nigel bates	-	7/8/2014
87	First market reaction was to bid up the stock. Wonder what stimulus it was respo	tom pope	-	7/2/2014
86	That’s a shelf registration for an unspecified amount; the amount will get fille	DewDiligence_on_SI	-	7/2/2014
85	bluebird bio files S-3ASR registration statement: investor.bluebirdbio.com	Biotech Jim	-	7/2/2014
84	I didn't think anything noteworthy was said in the Q&A, but you might di	DewDiligence_on_SI	-	7/1/2014
83	Here are the relevant 4 slides that sum up the technology of homing endonuclease	Biotech Jim	-	7/1/2014
82	You didn't miss much; very dry CC, IMO.	DewDiligence_on_SI	-	7/1/2014
81	Thanks here is the link for anyone interested. The replay is available now edg	ghmm	-	6/30/2014
80	bluebird bio buys the Seattle Washington private gene editing company Precision	Biotech Jim	-	6/30/2014
79	Thanks for the kudos. After having a private discussion with my bud Rick, I d	Biotech Jim	1	6/18/2014
78	Been busy, but clearly ought to have spent more time on this thread :-) Message	nigel bates	-	6/18/2014
77	<i>I never pulled the trigger. Bummer.</i> Like the guy in the Dil	tom pope	-	6/16/2014
76	Kudos to Biotech Jim on this one. Hope you loaded up. Was on my radar screen b	FiloF	1	6/16/2014
75	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (BLUE), a clinical-stage	nigel bates	-	6/16/2014
74	Thanks! I seem to have been search-challenged yesterday . . . Cheers, T	tuck	-	5/23/2014
73	Just note that the clinical trial you linked to is the USA one (HGB-204) and the	idos	-	5/23/2014
72	Thanks. Wedbush expects equal or better outcomes with the new vector, and expec	tuck	-	5/22/2014
71	When is transfusion independence established? Is six months too early for such a	idos	-	5/22/2014
70	Presenting at the same time is Xeleron, also in beta thalassemia. Their abstrac	tuck	-	5/22/2014
69	BLUE at EHA presenting beta thalassemia data >>24. Gene therapy, cellular	tuck	-	5/22/2014
68	Juno and MSK jiggered the protocol and restarted their trial. Two weeks from st	tuck	-	5/7/2014
67	The prospects for that union would be better if the female wasn't so cowed!	tom pope	-	4/13/2014
66	Spring has now sprung and love is in the air. At least in my neck of the woods.	Biotech Jim	1	4/11/2014
65	tuck- Thanks for posting that as I had not seen that. I have been away from	Biotech Jim	-	4/7/2014
64	Might need that safety switch: Juno trial hiccup Could be a rough Monday for t	tuck	-	4/6/2014

Go to reply# or date (mm/dd/yy):